標(biāo)題: Titlebook: Stroke Revisited: Dyslipidemia in Stroke; Seung-Hoon Lee,Min Kyoung Kang Book 2021 The Editor(s) (if applicable) and The Author(s), under [打印本頁] 作者: 悲傷我 時間: 2025-3-21 17:20
書目名稱Stroke Revisited: Dyslipidemia in Stroke影響因子(影響力)
書目名稱Stroke Revisited: Dyslipidemia in Stroke影響因子(影響力)學(xué)科排名
書目名稱Stroke Revisited: Dyslipidemia in Stroke網(wǎng)絡(luò)公開度
書目名稱Stroke Revisited: Dyslipidemia in Stroke網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Stroke Revisited: Dyslipidemia in Stroke被引頻次
書目名稱Stroke Revisited: Dyslipidemia in Stroke被引頻次學(xué)科排名
書目名稱Stroke Revisited: Dyslipidemia in Stroke年度引用
書目名稱Stroke Revisited: Dyslipidemia in Stroke年度引用學(xué)科排名
書目名稱Stroke Revisited: Dyslipidemia in Stroke讀者反饋
書目名稱Stroke Revisited: Dyslipidemia in Stroke讀者反饋學(xué)科排名
作者: 相容 時間: 2025-3-21 23:13
Book 2021r on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerat作者: FISC 時間: 2025-3-22 01:48 作者: 杠桿 時間: 2025-3-22 06:52 作者: Prognosis 時間: 2025-3-22 12:32
2522-5588 usses a range of specific considerations.Provides clear manaThis book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatme作者: NAVEN 時間: 2025-3-22 16:58
Role of Dyslipidemia in Atherosclerosisue to the development of intimal plaques. The formation of plaques involves the deposition of small cholesterol crystals in the intima and its underlying smooth muscle. The growth of plaques starts with the proliferation of fibrous tissues and the surrounding smooth muscle producing a bulge inside t作者: 吼叫 時間: 2025-3-22 20:39
Effects of Dyslipidemia on the Cerebral Vesselsone of the modifiable risk factors for stroke and increases the risk of stroke by 2.19 times [.]. Cholesterol can be largely divided into total cholesterol, triglyceride (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL). When the endothelial cell of blood vessels is damaged by 作者: 同來核對 時間: 2025-3-22 23:43 作者: 友好關(guān)系 時間: 2025-3-23 01:52 作者: 甜瓜 時間: 2025-3-23 06:46
Clinical Biomarkers of Dyslipidemiactors like total cholesterol LDL cholesterol and HDL cholesterol. However, apolipoproteins like Apo B100 sometimes can be better predictor for assessing the risk of the cardiovascular disease and stroke. The stroke pathomechanism is heterogeneous and multifactorial. Oxidative stress involves the inj作者: nonsensical 時間: 2025-3-23 11:43
Therapeutic Lifestyle Modificationts, whole grains, and fish intake is recommended. Avoid trans fats and reduce saturated fatty acid intake as much as possible. Reduce dietary simple carbohydrates and replace them with monounsaturated fats or polyunsaturated fats. Avoid added sugar and sugar-sweetened beverages. Limit alcohol use..(作者: 燕麥 時間: 2025-3-23 13:53
Statinsrols. The statins have been used for more than 30?years for the prevention of stroke and coronary artery disease. Their primary mechanism of action is via inhibition of the mevalonate pathway, resulting in a decrease of cholesterol and isoprenoid synthesis. Reduction of cholesterol synthesis enhance作者: Invertebrate 時間: 2025-3-23 21:42 作者: Kernel 時間: 2025-3-24 00:59 作者: 猛然一拉 時間: 2025-3-24 06:13
Fish Oils are the essential PUFAs found in fish oil. Early epidemiologic researches have shown a reverse relationship between fish consumption and the risk of coronary heart disease. Since then, several experimental investigations and clinical studies have demonstrated the advantages of fish oil supplementat作者: companion 時間: 2025-3-24 07:31
PCSK9 Inhibiting Monoclonal Antibodiestroke and TIAs. The current guidelines recommend the use of lipid-lowering medications to reduce the risk of stroke among patients with ischemic stroke or TIA presumed to be of atherosclerotic origin. Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, in addition to healt作者: TAP 時間: 2025-3-24 10:46
PCSK9 Inhibiting siRNAtilized of all therapies. However, patients who do not respond to statin therapy or other oral agents, or who develop side effects from taking the medications often need novel treatments. Inclisiran is a new and novel small interfering RNA compound which inhibits the translation of mRNA for Proprote作者: ELATE 時間: 2025-3-24 15:51
Understanding of Clinical Practice Guidelines for Dyslipidemialesterol Education Program-Adult Treatment Panel (NCEP-ATP) I in 1988, guidelines from many associations have evolved. ATP I through III and an updated version of ATP III have been released between 1988 and 2004. These guidelines established the core standards of dyslipidemia treatment and have iden作者: Basal-Ganglia 時間: 2025-3-24 19:15 作者: integrated 時間: 2025-3-25 01:17
Practical Dyslipidemia Management in Stroke-Specific Situationsprevention. Over the past several decades, remarkable developments in controlling dyslipidemia and a distinct decrease in subsequent cardiovascular events (CVD) have been achieved. This monumental change is due to the use of “statins” or “3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors,” 作者: 裹住 時間: 2025-3-25 06:41
Role of Dyslipidemia in Atherosclerosisines and chemokines (TNF-α, IL-1β, IL-6, MCP-1), and millions of different antigens. This makes the development of atherosclerosis very challenging. In addition to the development of myocardial infarctions, atherosclerosis is also associated with peripheral artery disease. This pathological conditio作者: 晚間 時間: 2025-3-25 08:33
Effects of Dyslipidemia on the Cerebral Vesselsscle cells, and their debris are cumulated under the endothelial cell lining. Then, the cumulated products form lipid cores, and these eventually form atheromatous plaques. High blood cholesterol, excluding HDL, eventually causes arteriosclerosis of blood vessels to narrow the diameter of the vessel作者: 專橫 時間: 2025-3-25 12:25
Impact of Dyslipidemia on Ischemic Stroke-scale clinical trials in stroke patients..Triglyceride (TG) level is high in many clinical situations and has influenced adverse cardiovascular diseases. Despite managing LDL-C adequately, residual risks still remain. Therefore, we must closely observe TGs for patients who are at high risk of ather作者: 殘酷的地方 時間: 2025-3-25 19:38
Dyslipidemia and Hemorrhagic Stroke in primary stroke prevention. In secondary stroke prevention, the risk of ICH showed a nonsignificant trend for statin therapy and was significantly associated with lipid-lowering therapy. The risk of ICH from statin or lipid-lowering therapy is offset by the prevention of ischemic stroke and subst作者: STAT 時間: 2025-3-25 23:09
Clinical Biomarkers of Dyslipidemiarly prediction and drug development. Here, we reviewed the use of nontraditional lipid biomarkers including apolipoproteins and lipid peroxidation and discussed the role of metabolomics and lipidomics in improving stroke risk evaluation and monitoring the drug effects.作者: 彎腰 時間: 2025-3-26 03:51 作者: FLIC 時間: 2025-3-26 04:36
Statinsding Rosuvastatin, Atorvastatin, Simvastatin, Fluvastatin, Pravastatin, Lovastatin, and Pitavastatin. The key pharmacological properties of each statin are slightly different according to their solubility and chemical features. As for their implications on stroke trials, the association between pre-作者: Hemodialysis 時間: 2025-3-26 11:06
Ezetimibelowering effects of ezetimibe, many clinicians are still not convinced of the clinical benefits of ezetimibe. This chapter aims to elucidate the developmental history, pharmacokinetic profiles, mechanisms of action, therapeutic adjustment for practical use, and clinical trial data that may support t作者: instate 時間: 2025-3-26 13:19
Fibrate and Niacin based on clinical trials. Also, recent studies have shown neutral results in that the application of combined niacin and statins can prevent stroke and cardiovascular diseases. Hence, in the future, the effect of fibrates and niacin in decreasing the residual risk of stroke and cardiovascular disea作者: 樹上結(jié)蜜糖 時間: 2025-3-26 17:39 作者: gangrene 時間: 2025-3-26 22:28 作者: Irascible 時間: 2025-3-27 05:12 作者: 強制令 時間: 2025-3-27 08:51
2522-5588 pidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge..978-981-16-3925-8978-981-16-3923-4Series ISSN 2522-5588 Series E-ISSN 2522-5596 作者: 條約 時間: 2025-3-27 13:09 作者: 過濾 時間: 2025-3-27 16:08
Zain Ahmed,Prerak Juthani,Megan Lee,Nihar R. Desai作者: 津貼 時間: 2025-3-27 19:28
Book 2021imely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge..作者: 小母馬 時間: 2025-3-28 00:22 作者: Foam-Cells 時間: 2025-3-28 05:56
https://doi.org/10.1007/978-981-16-3923-4dyslipidemia; stroke; atherosclerosis; cardiovascular disease; biomarker作者: Spangle 時間: 2025-3-28 08:23
Seung-Hoon Lee,Min Kyoung KangPresents state of the art knowledge.Covers both basic and clinical aspects in detail.Evaluates currently available treatment modalities.Discusses a range of specific considerations.Provides clear mana作者: 詼諧 時間: 2025-3-28 14:29 作者: 罐里有戒指 時間: 2025-3-28 17:16 作者: 忍耐 時間: 2025-3-28 19:43 作者: REP 時間: 2025-3-29 00:21 作者: interlude 時間: 2025-3-29 03:44
Chatbots an physischen Touchpointsnd:innen erstklassige Beratungs- und Servicequalit?t erwarten, wirken sich Personalengp?sse negativ aus. In-Store-Marketingtechnologien bzw. Chatbots in station?ren Settings k?nnten hier positive Effekte erzielen. So k?nnen Standardanfragen schnell und rund um die Uhr beantwortet werden. Der vorlieg作者: indubitable 時間: 2025-3-29 09:15 作者: synchronous 時間: 2025-3-29 13:29
Die Entwicklung des staatlichen Archivwesens in Thüringen und seine Beziehungen zur Landesgeschichts Archive diejenigen Forschungsst?tten, die für die Bereitstellung und Nutzbarmachung der Quellen an erster Stelle stehen. So sehr diese Tatsache im allgemeinen bekannt ist und so lebhaft die Archive für die geschichtlichen Arbeiten aller Gebiete heute benutzt werden, so wenig wei? man, wie die t?gli作者: 白楊 時間: 2025-3-29 17:42 作者: 主講人 時間: 2025-3-29 21:38 作者: 注意 時間: 2025-3-30 01:48 作者: Frenetic 時間: 2025-3-30 05:39
Johanna Johansen,Simone Fischer-Hübner history, or a professional photographer with a desire to add an extra revenue generating service, this book will be an invaluable aid. .? Shows how to acquire the best scans and digitize large photographs..? Teaches you how to digitally repair damaged prints, correct color shifts, reclaim lost deta作者: Obscure 時間: 2025-3-30 08:35 作者: TRAWL 時間: 2025-3-30 12:35
Genomic Imprintingder chromatin structures are heritable carriers of epigenetic information. This suggests that CTCF has a key role in the organization of chromatin architecture..In this chapter, we present CTCF as the critical nuclear protein for mediating the function of insulators. We will discuss different types 作者: ROOF 時間: 2025-3-30 16:38 作者: SHRIK 時間: 2025-3-30 23:49
2512-0506 lstudie arbeitet er individuelle Prozesse der überzeugungsentwicklung heraus, die Wirkungsweisen der Fortbildungen erkl?ren und Rückschlüsse auf deren weitere Optimierung zulassen.978-3-658-11881-5978-3-658-11882-2Series ISSN 2512-0506 Series E-ISSN 2512-1162 作者: tattle 時間: 2025-3-31 03:47 作者: VALID 時間: 2025-3-31 07:16
Programmable radar signal processing using the RAP,nature of radar computations is analyzed and parallel processing requirements are characterized. The effects of these requirements upon the design of the RAP are described. Features of the operational RAP system are discussed. Finally, an implementation of a Constant False Alarm Rate (CFAR) Processor is given.
